Categories Earnings, LATEST, Retail, U.S. Markets News

Unilever ditches London for Rotterdam

In a major setback for the UK government, Unilever plc (UL) said it is planning to consolidate its headquarters in the city of Rotterdam in the Netherlands instead of London. The consumer goods giant currently has two operating companies in the Netherlands and the UK with the two boards following different regulations in each country. Unilever said its decision to base its headquarters in Rotterdam instead of London is not related in any way to Brexit although this move is likely to impact the UK in terms of investment.

Unilever said it had chosen Rotterdam plainly due to the fact that the Netherlands entity was larger than the British one. The Dutch company holds about 55% of the combined share capital and has more trading liquidity than its UK counterpart.

(Image Courtesy: M.Minderhoud, Wikimedia Commons)

Unilever plans to restructure its operations more broadly into three divisions, each with its own headquarters. The company plans to base its beauty and personal care division as well as its home care division in the UK. The foods and refreshment unit will be based in Rotterdam.

Meanwhile, the company plans to continue investing in the UK on research and development. There will be no significant impact on jobs in both countries due to the latest decision.

The new structure is expected to provide Unilever with greater flexibility in making changes to its portfolio and in taking major decisions related to mergers and acquisitions.

Shares saw a slight drop in both London and Netherlands.

Although Unilever has denied that its decision has any connection to Brexit, one of the problems facing the UK is the likelihood of many large companies shifting base to the European Union for simplicity of doing business. This will have a negative impact on the UK economy.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top